India, Sept. 6 -- The Delhi drugs control department has suspended 235 pharmacy licences in 2024-25, the highest in the last three financial years, according to official data. The suspensions, described by the department as a "punitive action", were imposed for a range of violations by pharmacists across the city.

In the financial year 2024-25 (April to March), 235 licences were suspended and 14 cancelled for failing to comply with norms. This marks a significant increase compared to previous years: 179 suspensions and 38 cancellations were recorded in 2023-24, while 208 suspensions and 23 cancellations were reported in 2022-23. Over the past three years, the total stands at 622 suspensions and 75 cancellations.

Explaining the process, ...